Pharmaceutical Business review

Intuitive Surgical acquires rights to USGI Medical’s surgery technology

USGI’s incisionless surgery platform, the EndoSurgical Operating System (EOS), is designed to address a wide range of surgical indications. Surgeons and gastroenterologists currently use the EOS to perform endolumenal (procedures within the GI tract) and translumenal procedures through the body’s natural orifices (these are commonly referred to as ‘NOTES’ or Natural Orifice Translumenal Endoscopic Surgery).

Eliminating skin incisions may reduce the risk of infection and associated complications and may result in less post-operative pain, faster recovery time and no abdominal scars for patients.

Eugene Chen, CEO of USGI Medical, said: “We believe that mechanical and robotic solutions complement each other and together will advance and expand this field to a wider group of procedures and patients.”